These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5862841)

  • 41. [Some new findings on progressive muscular dystrophy].
    Sugita H
    Shinkei Kenkyu No Shimpo; 1965 Jul; 9(2):393-6. PubMed ID: 5893884
    [No Abstract]   [Full Text] [Related]  

  • 42. [Contribution to the study of creatine phosphokinase activity of the blood of experimental animals].
    Sánchez Ramos F
    Arch Inst Farmacol Exp (Madr); 1965; 17(1):53-69. PubMed ID: 5864227
    [No Abstract]   [Full Text] [Related]  

  • 43. SERUM CREATINE PHOSPHOKINASE IN MICE WITH MUSCULAR DYSTROPHY.
    NICHOL CJ
    Enzymol Biol Clin (Basel); 1964; 10():217-20. PubMed ID: 14227361
    [No Abstract]   [Full Text] [Related]  

  • 44. [Actions to be taken in case of muscle exercise intolerance].
    Laforêt P
    Rev Prat; 2008 Dec; 58(20):2261-4. PubMed ID: 19209657
    [No Abstract]   [Full Text] [Related]  

  • 45. Distal muscular dystrophy of the Miyoshi type.
    Yildiz H; Emre U; Coskun O; Ergün U; Atasoy HT; Inan LE
    Clin Neuropathol; 2003; 22(4):204-8. PubMed ID: 12908758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SERUM CREATINE PHOSPHOKINASE MEASUREMENTS IN MUSCULAR DYSTROPHY STUDIES.
    NICHOL CJ
    Clin Chim Acta; 1965 May; 11():404-7. PubMed ID: 14347986
    [No Abstract]   [Full Text] [Related]  

  • 47. No improvement in delay in diagnosis of Duchenne muscular dystrophy.
    Marshall PD; Galasko CS
    Lancet; 1995 Mar; 345(8949):590-1. PubMed ID: 7605512
    [No Abstract]   [Full Text] [Related]  

  • 48. [On the behavior of creatine-phosphokinase activity in the serum of patients with progressive muscular dystrophy].
    CUTILLO S; COLETTA A; REA F; BERNI CANANI M
    Boll Soc Ital Biol Sper; 1963 Jul; 39():769-72. PubMed ID: 14024396
    [No Abstract]   [Full Text] [Related]  

  • 49. Useful investigations in a refractory case of 'myositis'.
    MacDonald AG; Behan W; Hollman AS; Sturrock RD; Field M
    Br J Rheumatol; 1994 Aug; 33(8):761-4. PubMed ID: 8055204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The enzymatic diagnosis of myocardial infarction. I. The activity of glutamic oxaloacetic transaminase, of lactate dehydrogenase, of alpha-hydroxybutyrate dehydrogenase and creatine phosphokinase in myocardial infarction].
    Schneider KW; Lehmann FG
    Enzymol Biol Clin (Basel); 1966; 6(1):25-35. PubMed ID: 5908430
    [No Abstract]   [Full Text] [Related]  

  • 51. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
    Grimm T
    Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma creatine phosphokinase activity of chickens with hereditary muscular dystrophy.
    Holliday TA; Asmundson VS; Julian LM
    Enzymol Biol Clin (Basel); 1965; 5(4):209-16. PubMed ID: 5864513
    [No Abstract]   [Full Text] [Related]  

  • 53. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 54. Steroid-induced CPK estimation--a new diagnostic test for human muscular dystrophy and its carrier state.
    Sen S; Das PK
    Arch Dis Child; 1978 Jun; 53(6):521-2. PubMed ID: 686785
    [No Abstract]   [Full Text] [Related]  

  • 55. [Limb-girdle syndrome. A study of 46 cases].
    Ferrer X; Larrivière M; Coquet M; Ellie E; Lagueny A; Julien J
    Rev Neurol (Paris); 1993; 149(12):788-93. PubMed ID: 7997739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ["Vacuolar myopathy" and vacuolar degenerative aspects in neuromuscular pathology. Considerations based on the study of some personal cases].
    Buscaino GA; D'Arrigo B
    Acta Neurol (Napoli); 1966; 21(1):6-25. PubMed ID: 5999242
    [No Abstract]   [Full Text] [Related]  

  • 57. [The behavior of serum enzymes in progressive muscle dystrophies and progressive muscle atrophies].
    Pfeil B; Schmidt-Peter P; müller-Stephann H
    Padiatr Grenzgeb; 1967; 6(2):89-103. PubMed ID: 5588329
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the effect of corticoid administration on creatine phosphokinase in progressive muscular dystrophy].
    Barthelmai W
    Verh Dtsch Ges Inn Med; 1965; 71():624-6. PubMed ID: 5877674
    [No Abstract]   [Full Text] [Related]  

  • 59. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 60. ACTIVATION OF CREATINE PHOSPHOKINASE BY SULFHYDRYL COMPOUNDS IN NORMAL AND MUSCULAR DYSTROPHY SERA.
    KAR NC; PEARSON CM
    Proc Soc Exp Biol Med; 1965 Mar; 118():662-4. PubMed ID: 14264523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.